Draft monograph: amycretin

§1Consultation and window

§1.1Window

Opened

5 August 2026

Closed

2 September 2026

Duration

28 days

Status

Open — submissions are being received

Document under consultation

Monograph: Amycretin

Submissions received

16

§1.2Consultation questions

The secretariat put the following questions. A submission was not required to address them and several did not; the questions record what the Institute was uncertain about rather than restricting what a respondent could raise.

1. Is the low certainty rating correctly drawn, and is the maturity of the contributing evidence stated on the face of the rating?
2. Is the amylin component of the mechanism described in a way that distinguishes it from the amylin analogue monographs in the same series?
3. Are the evidence gaps recorded in the draft complete?

§1.3How a submission is handled

• Every submission is signed. The Institute publishes no anonymous submission.
• Every submission carries a declared interest. A declaration of no interest is itself a declaration and is recorded as one. A declaration is not a disqualification and the Institute has never given a submission less weight on that ground.
• A submission from an employee of a marketing-authorisation holder is identified as an industry submission on its face, following a unanimous consultation on the conflicts policy.
• Every submission receives a secretariat response and a disposition. Submissions that are not accepted remain published in full; the Institute does not remove a submission because it disagrees with it.
• There is no voting, no reputation score, no reply thread and no editing after receipt.

§1.4Making a submission